Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma
2 clinical trials · Condition
◉ Watch Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma (NCT03422536) | University of Arizona | 2017-12-05 |
| Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer (NCT02388932) | Case Comprehensive Cancer Center | 2015-03-03 |
Track Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.